Mark Wilson is a Partner at Norton Rose Fulbright, where his practice focuses on all aspects of patent prosecution and enforcement. He is a member of FICPI's Study & Work Group on Biotechnology and Pharmaceuticals (CET 5) and a member of FICPI's Finance Advisory Board. Sarah Eddy, Thomas Orsak, Mark Garrett, & Mark Wilson of global law firm Norton Rose Fulbright https://www.nortonrosefulbright.com/en-us